Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia

Last updated: March 2, 2023
Sponsor: The Hong Kong Polytechnic University
Overall Status: Completed

Phase

N/A

Condition

Mental Disability

Learning Disorders

Memory Loss

Treatment

N/A

Clinical Study ID

NCT04773171
HongKongPUDA
  • Ages 18-64
  • All Genders

Study Summary

Objective: To determine the efficacy of computer-assisted cognitive remediation (CACR) in patients with chronic schizophrenia in the community settings.

Study Design: Single-blinded prospective, pre-test/post-test randomized controlled trial (RCT) will be conducted in 2 groups of participants that receiving training in community settings. Treatment groups will attend individualized CACR programme using CogniPlus® while control group will continue attend conventional treatment as usual (TAU). Assessment on the means difference in assessing functions will be done after the study.

Samples: 80 patients with stable and chronic schizophrenia will be recruited from the community, using a sampling frame of selected diagnosis and homogeneity.

Expected Findings: Find out the training effects of selected CACR on EF and daily functioning in patients with schizophrenia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of schizophrenia, based on Diagnostic and statistical manual of mentaldisorders (5th ed.), at chronic and stable state
  • Age from 18 to 64
  • Regular attendance to rehabilitation training programmes
  • Willing and capable to participate and are voluntarily consent to the participation
  • Pass the cut-off point of referenced screening tests

Exclusion

Exclusion Criteria:

  • Comorbid differential diagnosis
  • History of organic brain disorder
  • Complicated conditions that preclude regular attendance of the training
  • Currently receiving computer-assisted cognitive remediation and other individualintensive cognitive training

Study Design

Total Participants: 72
Study Start date:
April 13, 2021
Estimated Completion Date:
November 30, 2022

Study Description

Schizophrenia is one of the most serious and disabling mental disorders. Prevalence of schizophrenia is about 1% worldwide. The related dysfunctions have great impact and burden to the concerned person and to the society. With increasing use of CR programmes in helping the patients to resume their capability in community living, the clinical outcome was not fully established especially on specific cognitive domains such as executive function (EF). The present study aims at evaluating the efficacy of CACR on developing EF and improving daily functioning. The result will provide information for therapists' future clinical decisions for patients' best reintegration into the societies. This also helps decrease the burden of family, society in the long run.

Connect with a study center

  • New Life Psychiatric Rehabilitation Association

    Hong Kong,
    Hong Kong

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.